These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 1613814)

  • 41.
    Joya A; Ardaya M; Montilla A; Garbizu M; Plaza-García S; Gómez-Vallejo V; Padro D; Gutiérrez JJ; Rios X; Ramos-Cabrer P; Cossío U; Pulagam KR; Higuchi M; Domercq M; Cavaliere F; Matute C; Llop J; Martín A
    Theranostics; 2021; 11(1):410-425. PubMed ID: 33391483
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Calcium-Binding Proteins in the Nervous System during Hibernation: Neuroprotective Strategies in Hypometabolic Conditions?
    Gattoni G; Bernocchi G
    Int J Mol Sci; 2019 May; 20(9):. PubMed ID: 31086053
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Central activation of the A
    Vicent MA; Borre ED; Swoap SJ
    J Comp Physiol B; 2017 Jul; 187(5-6):835-845. PubMed ID: 28378088
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Combination of therapeutic hypothermia and other neuroprotective strategies after an ischemic cerebral insult.
    Goossens J; Hachimi-Idrissi S
    Curr Neuropharmacol; 2014 Sep; 12(5):399-412. PubMed ID: 25426009
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Season primes the brain in an arctic hibernator to facilitate entrance into torpor mediated by adenosine A(1) receptors.
    Jinka TR; Tøien Ø; Drew KL
    J Neurosci; 2011 Jul; 31(30):10752-8. PubMed ID: 21795527
    [TBL] [Abstract][Full Text] [Related]  

  • 46. The pharmacology and molecular mechanisms underlying temperature regulation and torpor.
    Swoap SJ
    Biochem Pharmacol; 2008 Oct; 76(7):817-24. PubMed ID: 18644349
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Central nervous system regulation of mammalian hibernation: implications for metabolic suppression and ischemia tolerance.
    Drew KL; Buck CL; Barnes BM; Christian SL; Rasley BT; Harris MB
    J Neurochem; 2007 Sep; 102(6):1713-1726. PubMed ID: 17555547
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Recent developments in the discovery of novel adenosine kinase inhibitors: mechanism of action and therapeutic potential.
    McGaraughty S; Cowart M; Jarvis MF
    CNS Drug Rev; 2001; 7(4):415-32. PubMed ID: 11830758
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Striatum adenosine A2 receptors are modified during seizure: effect of cyclopentyladenosine administration.
    Giraldez L; Zanetti F; Girardi E
    Neurochem Res; 1999 Oct; 24(10):1217-23. PubMed ID: 10492516
    [TBL] [Abstract][Full Text] [Related]  

  • 50. CNS adenosine A1 receptors are altered after the administration of convulsant 3-mercaptopropionic acid and cyclopentyladenosine: an autoradiographic study.
    Giraldez L; Zanetti F; Antonelli MC; Rodríguez de Lores Arnaiz G; Girardi E
    Neurochem Res; 1998 Feb; 23(2):175-81. PubMed ID: 9475512
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Adenosine A1 receptor agonists as clinically viable agents for treatment of ischemic brain disorders.
    Bischofberger N; Jacobson KA; von Lubitz DK
    Ann N Y Acad Sci; 1997 Oct; 825():23-9. PubMed ID: 9369972
    [No Abstract]   [Full Text] [Related]  

  • 52. Postischemic administration of adenosine amine congener (ADAC): analysis of recovery in gerbils.
    Von Lubitz DK; Lin RC; Paul IA; Beenhakker M; Boyd M; Bischofberger N; Jacobson KA
    Eur J Pharmacol; 1996 Dec; 316(2-3):171-9. PubMed ID: 8982684
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Reduction of postischemic brain damage and memory deficits following treatment with the selective adenosine A1 receptor agonist.
    Von Lubitz DK; Beenhakker M; Lin RC; Carter MF; Paul IA; Bischofberger N; Jacobson KA
    Eur J Pharmacol; 1996 Apr; 302(1-3):43-8. PubMed ID: 8790990
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of N6-cyclopentyl adenosine and 8-cyclopentyl-1,3-dipropylxanthine on N-methyl-D-aspartate induced seizures in mice.
    Von Lubitz DK; Paul IA; Carter M; Jacobson KA
    Eur J Pharmacol; 1993 Nov; 249(3):265-70. PubMed ID: 8287913
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Mediation of the neuroprotective action of R-phenylisopropyl-adenosine through a centrally located adenosine A1 receptor.
    MacGregor DG; Miller WJ; Stone TW
    Br J Pharmacol; 1993 Sep; 110(1):470-6. PubMed ID: 8220909
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Chronic administration of selective adenosine A1 receptor agonist or antagonist in cerebral ischemia.
    Von Lubitz DK; Lin RC; Melman N; Ji XD; Carter MF; Jacobson KA
    Eur J Pharmacol; 1994 Apr; 256(2):161-7. PubMed ID: 8050467
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Chronic adenosine A1 receptor agonist and antagonist: effect on receptor density and N-methyl-D-aspartate induced seizures in mice.
    Von Lubitz DK; Paul IA; Ji XD; Carter M; Jacobson KA
    Eur J Pharmacol; 1994 Feb; 253(1-2):95-9. PubMed ID: 8013554
    [TBL] [Abstract][Full Text] [Related]  

  • 58. 'Therapeutic window's for multiple drug treatment of experimental cerebral ischemia in gerbils.
    Stanimirovic DB; Micic DV; Markovic M; Spatz M; Mrsulja BB
    Neurochem Res; 1994 Feb; 19(2):189-94. PubMed ID: 7910380
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Interaction between histamine and adenosine in human cerebromicrovascular endothelial cells: modulation of second messengers.
    Stanimirovic DB; Bertrand N; Merkel N; Bembry J; Spatz M
    Metab Brain Dis; 1994 Sep; 9(3):275-89. PubMed ID: 7838069
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adenosine A3 receptor stimulation and cerebral ischemia.
    Von Lubitz DK; Lin RC; Popik P; Carter MF; Jacobson KA
    Eur J Pharmacol; 1994 Sep; 263(1-2):59-67. PubMed ID: 7821362
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.